Nuo Therapeutics, Inc. engages in the development and sale of biomedical products for chronic wound care. It offers Aurix point of care technology for the separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Houston, TX.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company